287 related articles for article (PubMed ID: 11021529)
1. The CD28 and CTLA-4 receptors associate with the serine/threonine phosphatase PP2A.
Chuang E; Fisher TS; Morgan RW; Robbins MD; Duerr JM; Vander Heiden MG; Gardner JP; Hambor JE; Neveu MJ; Thompson CB
Immunity; 2000 Sep; 13(3):313-22. PubMed ID: 11021529
[TBL] [Abstract][Full Text] [Related]
2. Regulation of cytotoxic T lymphocyte-associated molecule-4 by Src kinases.
Chuang E; Lee KM; Robbins MD; Duerr JM; Alegre ML; Hambor JE; Neveu MJ; Bluestone JA; Thompson CB
J Immunol; 1999 Feb; 162(3):1270-7. PubMed ID: 9973379
[TBL] [Abstract][Full Text] [Related]
3. The inhibitory function of CTLA-4 does not require its tyrosine phosphorylation.
Baroja ML; Luxenberg D; Chau T; Ling V; Strathdee CA; Carreno BM; Madrenas J
J Immunol; 2000 Jan; 164(1):49-55. PubMed ID: 10604992
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of CTLA-4 function by the regulatory subunit of serine/threonine phosphatase 2A.
Baroja ML; Vijayakrishnan L; Bettelli E; Darlington PJ; Chau TA; Ling V; Collins M; Carreno BM; Madrenas J; Kuchroo VK
J Immunol; 2002 May; 168(10):5070-8. PubMed ID: 11994459
[TBL] [Abstract][Full Text] [Related]
5. The cytoplasmic domain of CD28 is both necessary and sufficient for costimulation of interleukin-2 secretion and association with phosphatidylinositol 3'-kinase.
Stein PH; Fraser JD; Weiss A
Mol Cell Biol; 1994 May; 14(5):3392-402. PubMed ID: 8164687
[TBL] [Abstract][Full Text] [Related]
6. CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression.
Carreno BM; Bennett F; Chau TA; Ling V; Luxenberg D; Jussif J; Baroja ML; Madrenas J
J Immunol; 2000 Aug; 165(3):1352-6. PubMed ID: 10903737
[TBL] [Abstract][Full Text] [Related]
7. Conversion of CTLA-4 from inhibitor to activator of T cells with a bispecific tandem single-chain Fv ligand.
Madrenas J; Chau LA; Teft WA; Wu PW; Jussif J; Kasaian M; Carreno BM; Ling V
J Immunol; 2004 May; 172(10):5948-56. PubMed ID: 15128776
[TBL] [Abstract][Full Text] [Related]
8. Negative-feedback regulation of CD28 costimulation by a novel mitogen-activated protein kinase phosphatase, MKP6.
Marti F; Krause A; Post NH; Lyddane C; Dupont B; Sadelain M; King PD
J Immunol; 2001 Jan; 166(1):197-206. PubMed ID: 11123293
[TBL] [Abstract][Full Text] [Related]
9. CTLA-4 suppresses proximal TCR signaling in resting human CD4(+) T cells by inhibiting ZAP-70 Tyr(319) phosphorylation: a potential role for tyrosine phosphatases.
Guntermann C; Alexander DR
J Immunol; 2002 May; 168(9):4420-9. PubMed ID: 11970985
[TBL] [Abstract][Full Text] [Related]
10. CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms.
Parry RV; Chemnitz JM; Frauwirth KA; Lanfranco AR; Braunstein I; Kobayashi SV; Linsley PS; Thompson CB; Riley JL
Mol Cell Biol; 2005 Nov; 25(21):9543-53. PubMed ID: 16227604
[TBL] [Abstract][Full Text] [Related]
11. Cutting edge: tyrosine-independent transmission of inhibitory signals by CTLA-4.
Cinek T; Sadra A; Imboden JB
J Immunol; 2000 Jan; 164(1):5-8. PubMed ID: 10604984
[TBL] [Abstract][Full Text] [Related]
12. Short cytoplasmic SDYMNM segment of CD28 is sufficient to convert CTLA-4 to a positive signaling receptor.
Yin L; Schneider H; Rudd CE
J Leukoc Biol; 2003 Jan; 73(1):178-82. PubMed ID: 12525576
[TBL] [Abstract][Full Text] [Related]
13. CTLA-4 ligation suppresses CD28-induced NF-kappaB and AP-1 activity in mouse T cell blasts.
Olsson C; Riesbeck K; Dohlsten M; Michaëlsson E
J Biol Chem; 1999 May; 274(20):14400-5. PubMed ID: 10318864
[TBL] [Abstract][Full Text] [Related]
14. Molecular basis of T cell inactivation by CTLA-4.
Lee KM; Chuang E; Griffin M; Khattri R; Hong DK; Zhang W; Straus D; Samelson LE; Thompson CB; Bluestone JA
Science; 1998 Dec; 282(5397):2263-6. PubMed ID: 9856951
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic T lymphocyte antigen-4 accumulation in the immunological synapse is regulated by TCR signal strength.
Egen JG; Allison JP
Immunity; 2002 Jan; 16(1):23-35. PubMed ID: 11825563
[TBL] [Abstract][Full Text] [Related]
16. Study of the interaction of the medium chain mu 2 subunit of the clathrin-associated adapter protein complex 2 with cytotoxic T-lymphocyte antigen 4 and CD28.
Follows ER; McPheat JC; Minshull C; Moore NC; Pauptit RA; Rowsell S; Stacey CL; Stanway JJ; Taylor IW; Abbott WM
Biochem J; 2001 Oct; 359(Pt 2):427-34. PubMed ID: 11583591
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic T lymphocyte antigen 4 (CTLA-4) inhibits CD28-induced IkappaBalpha degradation and RelA activation.
Pioli C; Gatta L; Frasca D; Doria G
Eur J Immunol; 1999 Mar; 29(3):856-63. PubMed ID: 10092088
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic T lymphocyte antigen 4 and CD28 modulate cell surface raft expression in their regulation of T cell function.
Martin M; Schneider H; Azouz A; Rudd CE
J Exp Med; 2001 Dec; 194(11):1675-81. PubMed ID: 11733581
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic analysis of CTLA-4 and CD28 expression during transient peptide-induced T cell activation in vivo.
Metzler B; Burkhart C; Wraith DC
Int Immunol; 1999 May; 11(5):667-75. PubMed ID: 10330272
[TBL] [Abstract][Full Text] [Related]
20. Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4.
Marengère LE; Waterhouse P; Duncan GS; Mittrücker HW; Feng GS; Mak TW
Science; 1996 May; 272(5265):1170-3. PubMed ID: 8638161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
